title: [Serious course of a miliary tuberculosis in a 34-year-old patient with ulcerative colitis and HIV infection under concomitant therapy with infliximab].
abstract: A 34-year-old HIV-positive patient with ulcerative colitis was transferred to the authors' hospital because of progressive worsening of his general condition with intermittent fever, increasing lymphopenia, anemia, thrombopenia and neutropenia under anti-tumor necrosis factor-(TNF-)alpha therapy with infliximab. In spite of negative screening tests before initiation of infliximab therapy and intermittent tests during treatment, miliary tuberculosis was finally diagnosed and a tuberculostatic therapy was started. The patient's clinical condition worsened due to the development of a serious exudative necrotizing pancreatitis which was likely to be caused by the tuberculostatic treatment. Due to severe pulmonary infiltrates and pleural effusions with respiratory failure the patient finally passed away.
authors.affiliation: Klinik für Gastroenterologie und Hepatologie, Universitäts Spital Zürich, Zürich, Schweiz.
authors.forename: Jonas
authors.initials: J
authors.lastname: Zeitz
authors.forename: Milo
authors.initials: M
authors.lastname: Huber
authors.forename: Gerhard
authors.initials: G
authors.lastname: Rogler
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis*; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000175:diagnosis* / Q000188:drug therapy*; D015897:Comorbidity; D003937:Diagnosis, Differential; D018450:Disease Progression; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D006801:Humans; D000069285:Infliximab; D008297:Male; D010179:Pancreas / Q000473:pathology; D019283:Pancreatitis, Acute Necrotizing / Q000175:diagnosis; D014057:Tomography, X-Ray Computed; D014391:Tuberculosis, Miliary / Q000175:diagnosis* / Q000188:drug therapy
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000995:Antitubercular Agents; D000069285:Infliximab
references.citation: J Rheumatol. 2007 Jun;34(6):1353-5
references.pmid: 17552060
references.citation: Gut. 2008 Mar;57(3):425; author reply 425-6
references.pmid: 18268059
references.citation: N Engl J Med. 2007 Jul 19;357(3):239-50
references.pmid: 17634459
references.citation: Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):907-13
references.pmid: 18470544
references.citation: Ann Intern Med. 2008 Aug 5;149(3):177-84
references.pmid: 18593687
references.citation: Autoimmun Rev. 2008 Dec;8(2):147-52
references.pmid: 18706526
references.citation: Lancet. 2002 May 4;359(9317):1541-9
references.pmid: 12047962
references.citation: N Engl J Med. 1997 Oct 9;337(15):1029-35
references.pmid: 9321530
references.citation: Autoimmun Rev. 2008 Dec;8(2):100-3
references.pmid: 18694850
references.citation: Swiss Med Wkly. 2007 Nov 3;137(43-44):620-2
references.pmid: 17990157
references.citation: N Engl J Med. 2004 Feb 26;350(9):876-85
references.pmid: 14985485
references.citation: Curr Opin Infect Dis. 2009 Aug;22(4):403-9
references.pmid: 19491672
references.citation: Clin Infect Dis. 2005 Aug 1;41 Suppl 3:S199-203
references.pmid: 15983900
references.citation: Gastroenterology. 2005 Jun;128(7):1805-11
references.pmid: 15940615
references.citation: Ann Rheum Dis. 2008 May;67(5):710-2
references.pmid: 18079191
references.citation: N Engl J Med. 2007 Jul 19;357(3):228-38
references.pmid: 17634458
references.citation: N Engl J Med. 2001 Oct 11;345(15):1098-104
references.pmid: 11596589
references.citation: Int J Tuberc Lung Dis. 1998 Jun;2(6):443-50
references.pmid: 9626600
references.citation: N Engl J Med. 2005 Dec 8;353(23):2462-76
references.pmid: 16339095
references.citation: Arthritis Rheum. 2009 Jul;60(7):1884-94
references.pmid: 19565495
references.citation: Aliment Pharmacol Ther. 2010 Jan;31(1):20-34
references.pmid: 19681818